William M. Pardridge
Active 1975–2023
- Also published as
- WILLIAM M. PARDRIDGE
- 213
- Papers
- 42,369
- Citations
- 119
- h-index
- 213
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine34.6%
- Biochemistry, Genetics and Molecular Biology21.9%
- Neuroscience21%
- Materials Science7.9%
- Engineering4.5%
- Pharmacology, Toxicology and Pharmaceutics3%
- Other7.1%
Topics
- RNA Interference and Gene Delivery4.6%
- Nanoparticle-Based Drug Delivery4.1%
- Barrier Structure and Function Studies4.1%
- Drug Transport and Resistance Mechanisms3.6%
- Alzheimer's disease research and treatments2.6%
- Advanced Drug Delivery Systems2%
- Other79%
Coauthors
- Rubén J. Boado51
- Yun Zhang26
- William H. Oldendorf10
- Young‐Sook Kang9
- Ulrich Bickel8
- Yufeng Zhang8
- Jing Yang7
- Lawrence J. Mietus7
- Dafang Wu6
- Eric Ka‐Wai Hui6
- Jeff Zhiqiang Lu6
- Jody Eisenberg6
- Chunni Zhu5
- Chun‐Fang Xia5
- Domingo Triguero5
- Felix Schlachetzki5
- Rachita K. Sumbria5
- Arno K. Kumagai4
- Harrison J.L. Frank4
- Hwa Jeong Lee4
- J Buciak4
- Jian Yi Li4
- Leon D. Braun4
- Ningya Shi4
All papers
- The blood-brain barrier: Bottleneck in brain drug development
Authors: William M. Pardridge - NeuroRx 2004 cited by 2,724
- Drug Transport across the Blood–Brain Barrier
Authors: William M. Pardridge - Journal of Cerebral Blood Flow & Metabolism 2012 cited by 1,949
- Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain
Authors: William M. Pardridge - Frontiers in Aging Neuroscience 2020 cited by 384
- A Historical Review of Brain Drug Delivery
Authors: William M. Pardridge - Pharmaceutics 2022 cited by 212
- Blood–brain barrier delivery
Authors: William M. Pardridge - Drug Discovery Today 2006 cited by 1,186
- CSF, blood-brain barrier, and brain drug delivery
Authors: William M. Pardridge - Expert Opinion on Drug Delivery 2016 cited by 511
- Treatment of Alzheimer’s Disease and Blood–Brain Barrier Drug Delivery
Authors: William M. Pardridge - Pharmaceuticals 2020 cited by 190
- Drug transport in brain via the cerebrospinal fluid
Authors: William M. Pardridge - Fluids and Barriers of the CNS 2011 cited by 316
- Delivery of peptides and proteins through the blood–brain barrier
Authors: Ulrich Bickel, Takayoshi Yoshikawa, William M. Pardridge - Advanced Drug Delivery Reviews 2001 cited by 473
- Drug Targeting to the Brain
Authors: William M. Pardridge - Pharmaceutical Research 2007 cited by 451
- Selective expression of the large neutral amino acid transporter at the blood–brain barrier
Authors: Rubén J. Boado, Jian Yi Li, Marie Nagaya, Crystal Zhang, William M. Pardridge - National Academy of Sciences, Proceedings of the National Academy of Sciences 1999 cited by 479
- Blood–brain barrier endogenous transporters as therapeutic targets: a new model for small molecule CNS drug discovery
Authors: William M. Pardridge - Expert Opinion on Therapeutic Targets 2015 cited by 154
- Brain gene therapy with Trojan horse lipid nanoparticles
Authors: William M. Pardridge - Trends in Molecular Medicine 2023 cited by 51
- BLOOD-BRAIN BARRIER DRUG TARGETING: THE FUTURE OF BRAIN DRUG DEVELOPMENT
Authors: William M. Pardridge - Molecular Interventions 2003 cited by 708
- Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trial
Authors: Roberto Giugliani, Luciana Giugliani, Fabiano de Oliveira Poswar, Karina Carvalho Donis, Amauri Dalla Corte, Mathias Schmidt, Rubén J. Boado, Igor Nestrašil, Carol Nguyen, Steven Chen, William M. Pardridge - Orphanet Journal of Rare Diseases 2018 cited by 139
- Receptor-mediated drug delivery of bispecific therapeutic antibodies through the blood-brain barrier
Authors: William M. Pardridge - Frontiers in Drug Delivery 2023 cited by 57
- Strategies to advance translational research into brain barriers
Authors: Edward A. Neuwelt, N. Joan Abbott, Lauren E. Abrey, William A. Banks, Brian W. Blakley, Thomas P. Davis, Britta Engelhardt, Paula Grammas, Maiken Nedergaard, John G. Nutt, William M. Pardridge, Gary A. Rosenberg, Quentin R. Smith, Lester R. Drewes - The Lancet Neurology 2008 cited by 469
- Delivery of Biologics Across the Blood–Brain Barrier with Molecular Trojan Horse Technology
Authors: William M. Pardridge - BioDrugs 2017 cited by 152
- Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo.
Authors: William M. Pardridge, Jody L. Buciak, Phillip M. Friden - Journal of Pharmacology and Experimental Therapeutics 1991 cited by 362
- Human Insulin Receptor Monoclonal Antibody Undergoes High Affinity Binding to Human Brain Capillaries in Vitro and Rapid Transcytosis Through the Blood–Brain Barrier in Vivo in the Primate
Authors: William M. Pardridge, Young‐Sook Kang, Jody L. Buciak, Jing Yang - Pharmaceutical Research 1995 cited by 313
- CNS Drug Design Based on Principles of Blood‐Brain Barrier Transport
Authors: William M. Pardridge - Journal of Neurochemistry 1998 cited by 462
- Blood-brain barrier biology and methodology
Authors: William M. Pardridge - Journal of NeuroVirology 1999 cited by 444
- Blood–Brain Barrier Penetrating Biologic TNF-α Inhibitor for Alzheimer’s Disease
Authors: Rudy Chang, Jillian Knox, Jae H. Chang, Aram Derbedrossian, Vitaly Vasilevko, David H. Cribbs, Rubén J. Boado, William M. Pardridge, Rachita K. Sumbria - Molecular Pharmaceutics 2017 cited by 127
- Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization.
Authors: William M. Pardridge, Rubén J. Boado, Christine R. Farrell - Journal of Biological Chemistry 1990 cited by 604
